×

Category: Op-Ed

Trying to find a single cause of aging is like blinedfolded people trying to work out something is an elephant.
In the Proceedings of the National Academy of Science, Dr. Jesse Poganik and Prof. Vadim Gladyshev of Harvard Medical School have presented an opinion proposing a consensus understanding of aging. A problem of focus and funding The authors lament a lack of focus and funding in the field of gerontology, noting that a full 60%...
Joppe Nieuwenhuis
Joppe Nieuwenhuis, Innovation Scout at Rejuveron Life Sciences, discusses his views about the future of longevity and rejuvenation research and how it will merge with current medical frameworks and systems. About Rejuveron Rejuveron is a clinical-stage biotechnology company creating therapies to improve healthy aging. Its experienced drug discovery and development team applies a deep understanding...
ALEC is a lifespan comparison tool for researchers.
Dr. Leon Peshkin talks us through a new open access research tool he has helped to develop. The Animal Life Expectancy Comparisons Research Tool (ALEC) is free for researchers to use now. If a drug increases lifespan in mice by 15%, should I take it? The idea of intervention testing in a model organism is simple:...
TruDiagnostic logo
With so many health and disease outcomes connected to the biological aging processes, research into quantifying and tracking aging has surged in recent years due to the work of Steve Horvath, Morgan Levine, and others. Currently, epigenetic analysis of biological aging is thought to be the most comprehensive and accurate measurement of aging that is...
Mikhail Batin from Openlongevity
The life extension community has a number of long serving people in its ranks, and one of the longest-active of those in Russia is Mikhail Batin. His activities go way back to 2008 when the non-profit organization Science for Life Extension Foundation, which was first created with the mission to support scientific research to develop...
The senate building.
The good news is that the United States Senate has a Special Committee on Aging. The bad news is that it has little to do with the actual processes of aging and has not meaningfully furthered the research necessary to develop medical treatments for aging itself. Instead, the committee focuses its work on other issues...